Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 211

1.

Direct and Indirect Costs of Immunoglobulin Replacement Therapy in Patients with Common Variable Immunodeficiency (CVID) and X-Linked Agammaglobulinemia (XLA) in Italy.

Viti R, Marcellusi A, Capone A, Matucci A, Vultaggio A, Pignata C, Spadaro G, Vacca A, Marasco C, Agostini C, Mennini FS.

Clin Drug Investig. 2018 Sep 6. doi: 10.1007/s40261-018-0688-3. [Epub ahead of print]

PMID:
30191508
2.

The use of intravenous versus subcutaneous monoclonal antibodies in the treatment of severe asthma: a review.

Matucci A, Vultaggio A, Danesi R.

Respir Res. 2018 Aug 16;19(1):154. doi: 10.1186/s12931-018-0859-z. Review.

3.

Biweekly Hizentra® in Primary Immunodeficiency: a Multicenter, Observational Cohort Study (IBIS).

Vultaggio A, Azzari C, Ricci S, Martire B, Palladino V, Gallo V, Pecoraro A, Pignata C, Spadaro G, Graziani S, Moschese V, Trizzino A, Boggia GM, Matucci A.

J Clin Immunol. 2018 Jul;38(5):602-609. doi: 10.1007/s10875-018-0528-5. Epub 2018 Jun 28.

4.

Efficacy and Safety of Mepolizumab (Anti-Interleukin-5) Treatment in Gleich's Syndrome.

Matucci A, Liotta F, Vivarelli E, Dies L, Annunziato F, Piccinni MP, Nencini F, Pratesi S, Maggi E, Vultaggio A.

Front Immunol. 2018 May 29;9:1198. doi: 10.3389/fimmu.2018.01198. eCollection 2018.

5.

Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question?

Matucci A, Vultaggio A, Maggi E, Kasujee I.

Respir Res. 2018 Jun 8;19(1):113. doi: 10.1186/s12931-018-0813-0. Review.

6.

Discovery of β-Adrenergic Receptors Blocker-Carbonic Anhydrase Inhibitor Hybrids for Multitargeted Antiglaucoma Therapy.

Nocentini A, Ceruso M, Bua S, Lomelino CL, Andring JT, McKenna R, Lanzi C, Sgambellone S, Pecori R, Matucci R, Filippi L, Gratteri P, Carta F, Masini E, Selleri S, Supuran CT.

J Med Chem. 2018 Jun 28;61(12):5380-5394. doi: 10.1021/acs.jmedchem.8b00625. Epub 2018 Jun 13.

PMID:
29851481
7.

IgG4 anti-infliximab in treated patients: clinical impact and temporal evolution.

Vultaggio A, Nencini F, Carraresi A, Pratesi S, Movérare R, Eriksson C, Venemalm L, Maggi E, Matucci A.

Allergy. 2018 May 2. doi: 10.1111/all.13471. [Epub ahead of print]

PMID:
29719053
8.

The Kinetics of Antidrug Antibodies, Drug Levels, and Clinical Outcomes in Infliximab-Exposed Patients with Immune-Mediated Disorders.

Nencini F, Vultaggio A, Pratesi S, Cammelli D, Milla M, Fiori G, Bagnoli S, Prignano F, Romagnani S, Maggi E, Matucci A.

J Allergy Clin Immunol Pract. 2018 Apr 13. pii: S2213-2198(18)30278-2. doi: 10.1016/j.jaip.2018.04.007. [Epub ahead of print]

PMID:
29660428
9.

1-[3-(4-Butylpiperidin-1-yl)propyl]-1,2,3,4-tetrahydroquinolin-2-one (77-LH-28-1) as a Model for the Rational Design of a Novel Class of Brain Penetrant Ligands with High Affinity and Selectivity for Dopamine D4 Receptor.

Del Bello F, Bonifazi A, Giorgioni G, Cifani C, Micioni Di Bonaventura MV, Petrelli R, Piergentili A, Fontana S, Mammoli V, Yano H, Matucci R, Vistoli G, Quaglia W.

J Med Chem. 2018 Apr 26;61(8):3712-3725. doi: 10.1021/acs.jmedchem.8b00265. Epub 2018 Apr 6.

PMID:
29589445
10.

Late sodium current inhibitors to treat exercise-induced obstruction in hypertrophic cardiomyopathy: an in vitro study in human myocardium.

Ferrantini C, Pioner JM, Mazzoni L, Gentile F, Tosi B, Rossi A, Belardinelli L, Tesi C, Palandri C, Matucci R, Cerbai E, Olivotto I, Poggesi C, Mugelli A, Coppini R.

Br J Pharmacol. 2018 Jul;175(13):2635-2652. doi: 10.1111/bph.14223. Epub 2018 May 3.

11.

Daughter-cell-specific modulation of nuclear pore complexes controls cell cycle entry during asymmetric division.

Kumar A, Sharma P, Gomar-Alba M, Shcheprova Z, Daulny A, Sanmartín T, Matucci I, Funaya C, Beato M, Mendoza M.

Nat Cell Biol. 2018 Apr;20(4):432-442. doi: 10.1038/s41556-018-0056-9. Epub 2018 Mar 12.

12.

Factors reducing omalizumab response in severe asthma.

Sposato B, Scalese M, Milanese M, Masieri S, Cavaliere C, Latorre M, Scichilone N, Matucci A, Vultaggio A, Ricci A, Cresti A, Santus P, Perrella A, Paggiaro PL.

Eur J Intern Med. 2018 Jun;52:78-85. doi: 10.1016/j.ejim.2018.01.026. Epub 2018 Feb 1.

PMID:
29395935
13.

Tocilizumab in Giant Cell Arteritis: A Real-Life Retrospective Study.

Vitiello G, Orsi Battaglini C, Carli G, Radice A, Matucci A, Vultaggio A, Olianti C, Parronchi P, Maggi E, Cammelli D.

Angiology. 2018 Oct;69(9):763-769. doi: 10.1177/0003319717753223. Epub 2018 Jan 17.

PMID:
29343075
14.

Immunoglobulin replacement therapy for yellow nail syndrome.

Lo Conte C, Allegrini C, Matucci A, Bartolucci M, Rosi E, Camiciottoli G, Amendola M, Pistolesi M, Bargagli E.

Scand J Immunol. 2018 Mar;87(3). doi: 10.1111/sji.12639. Epub 2018 Jan 10. No abstract available.

PMID:
29280506
15.

Combined capillary-venous-lymphatic malformations without overgrowth in patients with Klippel-Trénaunay syndrome.

Brandigi E, Torino G, Messina M, Molinaro F, Mazzei O, Matucci T, López Gutiérrez JC.

J Vasc Surg Venous Lymphat Disord. 2018 Mar;6(2):230-236. doi: 10.1016/j.jvsv.2017.09.011. Epub 2017 Dec 8.

PMID:
29233587
16.

Different Skin Prick Test Sensitization Patterns Do Not Influence the Response to Omalizumab in Severe Asthma.

Sposato B, Scalese M, Milanese M, Masieri S, Cavaliere C, Latorre M, Scichilone N, Matucci A, Vultaggio A, Ricci A, Cresti A, Paggiaro PL.

J Investig Allergol Clin Immunol. 2017;27(6):388-391. doi: 10.18176/jiaci.0196. No abstract available.

17.

Young Human Cholinergic Neurons Respond to Physiological Regulators and Improve Cognitive Symptoms in an Animal Model of Alzheimer's Disease.

Morelli A, Sarchielli E, Guarnieri G, Coppi E, Pantano D, Comeglio P, Nardiello P, Pugliese AM, Ballerini L, Matucci R, Ambrosini S, Castronovo G, Valente R, Mazzanti B, Bucciantini S, Maggi M, Casamenti F, Gallina P, Vannelli GB.

Front Cell Neurosci. 2017 Oct 27;11:339. doi: 10.3389/fncel.2017.00339. eCollection 2017.

18.

Corrigendum to "Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia" [Int. Immunopharmacol. 44 (2017) 38-42].

Spadaro G, Vultaggio A, Bosi A, Reichert D, Janssen J, Lamacchia D, Nappi L, Pecoraro A, Milito C, Ferraro A, Matucci A, Bacchiarri F, Carrai V, Hibbeler A, Speckman E, Guarnieri C, Bongiovanni S, Quinti I.

Int Immunopharmacol. 2018 Apr;57:201. doi: 10.1016/j.intimp.2017.10.014. Epub 2017 Oct 28. No abstract available.

PMID:
29089244
19.

3-Iodothyroacetic acid (TA1), a by-product of thyroid hormone metabolism, reduces the hypnotic effect of ethanol without interacting at GABA-A receptors.

Laurino A, Landucci E, Resta F, De Siena G, Matucci R, Masi A, Raimondi L.

Neurochem Int. 2018 May;115:31-36. doi: 10.1016/j.neuint.2017.10.008. Epub 2017 Oct 12.

PMID:
29032008
20.

Circulating tumor cells and microemboli can differentiate malignant and benign pulmonary lesions.

Mascalchi M, Maddau C, Sali L, Bertelli E, Salvianti F, Zuccherelli S, Matucci M, Borgheresi A, Raspanti C, Lanzetta M, Falchini M, Mazza E, Vella A, Luconi M, Pinzani P, Pazzagli M.

J Cancer. 2017 Jul 15;8(12):2223-2230. doi: 10.7150/jca.18418. eCollection 2017.

21.

Targeted therapy in severe asthma today: focus on immunoglobulin E.

Pelaia G, Canonica GW, Matucci A, Paolini R, Triggiani M, Paggiaro P.

Drug Des Devel Ther. 2017 Jun 29;11:1979-1987. doi: 10.2147/DDDT.S130743. eCollection 2017. Review.

22.

IL-10-Producing Infliximab-Specific T Cells Regulate the Antidrug T Cell Response in Exposed Patients.

Vultaggio A, Nencini F, Pratesi S, Cammelli D, Totaro M, Romagnani S, Maggi E, Matucci A; ABIRISK Consortium.

J Immunol. 2017 Aug 15;199(4):1283-1289. doi: 10.4049/jimmunol.1700008. Epub 2017 Jul 17.

23.

Screening protocols to monitor respiratory status in primary immunodeficiency disease: findings from a European survey and subclinical infection working group.

Jolles S, Sánchez-Ramón S, Quinti I, Soler-Palacín P, Agostini C, Florkin B, Couderc LJ, Brodszki N, Jones A, Longhurst H, Warnatz K, Haerynck F, Matucci A, de Vries E.

Clin Exp Immunol. 2017 Nov;190(2):226-234. doi: 10.1111/cei.13012. Epub 2017 Aug 25.

24.

Home infusion program with enzyme replacement therapy for Fabry disease: The experience of a large Italian collaborative group.

Concolino D, Amico L, Cappellini MD, Cassinerio E, Conti M, Donati MA, Falvo F, Fiumara A, Maccarone M, Manna R, Matucci A, Musumeci MB, Nicoletti A, Nisticò R, Papadia F, Parini R, Peluso D, Pensabene L, Pisani A, Pistone G, Rigoldi M, Romani I, Tenuta M, Torti G, Veroux M, Zachara E.

Mol Genet Metab Rep. 2017 Jun 22;12:85-91. doi: 10.1016/j.ymgmr.2017.06.005. eCollection 2017 Sep.

25.

Novel muscarinic acetylcholine receptor hybrid ligands embedding quinuclidine and 1,4-dioxane fragments.

Del Bello F, Bonifazi A, Giorgioni G, Petrelli R, Quaglia W, Altomare A, Falcicchio A, Matucci R, Vistoli G, Piergentili A.

Eur J Med Chem. 2017 Sep 8;137:327-337. doi: 10.1016/j.ejmech.2017.06.004. Epub 2017 Jun 3.

PMID:
28609709
26.

New insights in the metabolism of oxybutynin: evidence of N-oxidation of propargylamine moiety and rearrangement to enaminoketone.

Aprile S, Canavesi R, Matucci R, Bellucci C, Del Grosso E, Grosa G.

Xenobiotica. 2018 May;48(5):478-487. doi: 10.1080/00498254.2017.1342288. Epub 2017 Jul 6.

PMID:
28608746
27.

Miescher's cheilitis: Surgical management and long term outcome of an extremely severe case.

Innocenti A, Innocenti M, Taverna C, Melita D, Mori F, Ciancio F, De Giorgi V, Parronchi P, Vultaggio A, Matucci A.

Int J Surg Case Rep. 2017;31:241-244. doi: 10.1016/j.ijscr.2017.01.062. Epub 2017 Jan 30.

28.

Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia.

Spadaro G, Vultaggio A, Alberto Bosi A, Reichert D, Janssen J, Lamacchia D, Nappi L, Pecoraro A, Milito C, Ferraro A, Matucci A, Bacchiarri F, Carrai V, Hibbeler A, Speckman E, Guarnieri C, Bongiovanni S, Quinti I.

Int Immunopharmacol. 2017 Mar;44:38-42. doi: 10.1016/j.intimp.2016.12.030. Epub 2017 Jan 7. Erratum in: Int Immunopharmacol. 2018 Apr;57:201.

PMID:
28073042
29.

Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies.

Canessa C, Iacopelli J, Pecoraro A, Spadaro G, Matucci A, Milito C, Vultaggio A, Agostini C, Cinetto F, Danieli MG, Gambini S, Marasco C, Trizzino A, Vacca A, De Mattia D, Martire B, Plebani A, Di Gioacchino M, Gatta A, Finocchi A, Licciardi F, Martino S, De Carli M, Moschese V, Azzari C.

Int J Immunopathol Pharmacol. 2017 Mar;30(1):73-82. doi: 10.1177/0394632016681577. Epub 2016 Dec 7.

30.

Influence of anti-TNF immunogenicity on safety in rheumatic disease: a narrative review.

Matucci A, Cammelli D, Cantini F, Goletti D, Marino V, Milano GM, Scarpa R, Tocci G, Maggi E, Vultaggio A.

Expert Opin Drug Saf. 2016 Dec;15(sup1):3-10. Review.

PMID:
27924646
31.

Cardiovascular outcomes and tumour necrosis factor antagonists in chronic inflammatory rheumatic disease: a focus on rheumatoid arthritis.

Tocci G, Goletti D, Marino V, Matucci A, Milano GM, Cantini F, Scarpa R.

Expert Opin Drug Saf. 2016 Dec;15(sup1):55-61. Review.

PMID:
27924645
32.

Risk of malignancies using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis.

Bonovas S, Minozzi S, Lytras T, González-Lorenzo M, Pecoraro V, Colombo S, Polloni I, Moja L, Cinquini M, Marino V, Goletti D, Matucci A, Tocci G, Milano GM, Scarpa R, Cantini F.

Expert Opin Drug Saf. 2016 Dec;15(sup1):35-54. Review.

PMID:
27924644
33.

Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis.

Minozzi S, Bonovas S, Lytras T, Pecoraro V, González-Lorenzo M, Bastiampillai AJ, Gabrielli EM, Lonati AC, Moja L, Cinquini M, Marino V, Matucci A, Milano GM, Tocci G, Scarpa R, Goletti D, Cantini F.

Expert Opin Drug Saf. 2016 Dec;15(sup1):11-34. Review.

34.

3-iodothyronamine (T1AM), a novel antagonist of muscarinic receptors.

Laurino A, Matucci R, Vistoli G, Raimondi L.

Eur J Pharmacol. 2016 Dec 15;793:35-42. doi: 10.1016/j.ejphar.2016.10.027. Epub 2016 Nov 2.

PMID:
27815171
35.

An overview on safety of monoclonal antibodies.

Matucci A, Nencini F, Pratesi S, Maggi E, Vultaggio A.

Curr Opin Allergy Clin Immunol. 2016 Dec;16(6):576-581. Review.

PMID:
27749360
36.

Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions.

Vultaggio A, Petroni G, Pratesi S, Nencini F, Cammelli D, Milla M, Prignano F, Annese V, Romagnani S, Maggi E, Matucci A; ABIRISK Consortium.

Clin Exp Immunol. 2016 Dec;186(3):364-372. doi: 10.1111/cei.12858. Epub 2016 Oct 26.

37.

Effects of omalizumab in severe asthmatics across ages: A real life Italian experience.

Sposato B, Scalese M, Latorre M, Scichilone N, Matucci A, Milanese M, Masieri S, Rolla G, Steinhilber G, Rosati Y, Vultaggio A, Folletti I, Baglioni S, Bargagli E, Di Tomassi M, Pio R, Pio A, Maccari U, Maggiorelli C, Migliorini MG, Vignale L, Pulerà N, Carpagnano GE, Foschino Barbaro MP, Perrella A, Paggiaro PL.

Respir Med. 2016 Oct;119:141-149. doi: 10.1016/j.rmed.2016.09.005. Epub 2016 Sep 4.

38.

How the immune system responds to therapeutic biological agents.

Vultaggio A, Petroni G, Pratesi S, Nencini F, Cammelli D, Ferraro A, Maggi E, Matucci A.

J Int Med Res. 2016 Sep;44(1 suppl):38-42.

39.

The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over α1-adrenoceptor and D2-like receptor subtypes.

Del Bello F, Bonifazi A, Giannella M, Giorgioni G, Piergentili A, Petrelli R, Cifani C, Micioni Di Bonaventura MV, Keck TM, Mazzolari A, Vistoli G, Cilia A, Poggesi E, Matucci R, Quaglia W.

Eur J Med Chem. 2017 Jan 5;125:233-244. doi: 10.1016/j.ejmech.2016.09.026. Epub 2016 Sep 9.

PMID:
27662034
40.

GISCi: an opportunity for more consideration and visibility for young researchers.

Carozzi FM, Giorgi Rossi P, Matucci M, Iossa A, Del Mistro A, Maina G, Venturino E, Taddei GL, Giaimo MD.

Epidemiol Prev. 2016 May-Aug;40(3-4):150. doi: 10.19191/EP16.3-4.AD01.075. No abstract available.

41.

The safety of monoclonal antibodies in asthma.

Passalacqua G, Matucci A, Vultaggio A, Bagnasco D, Mincarini M, Maggi E, Canonica GW.

Expert Opin Drug Saf. 2016 Aug;15(8):1087-95. doi: 10.1080/14740338.2016.1186641. Review.

PMID:
27215447
43.

Carbachol dimers as homobivalent modulators of muscarinic receptors.

Matucci R, Nesi M, Martino MV, Bellucci C, Manetti D, Ciuti E, Mazzolari A, Dei S, Guandalini L, Teodori E, Vistoli G, Romanelli MN.

Biochem Pharmacol. 2016 May 15;108:90-101. doi: 10.1016/j.bcp.2016.03.012. Epub 2016 Mar 17.

PMID:
26996304
44.

Understanding Oxadiazolothiazinone Biological Properties: Negative Inotropic Activity versus Cytochrome P450-Mediated Metabolism.

Carosati E, Cosimelli B, Ioan P, Severi E, Katneni K, Chiu FC, Saponara S, Fusi F, Frosini M, Matucci R, Micucci M, Chiarini A, Spinelli D, Budriesi R.

J Med Chem. 2016 Apr 14;59(7):3340-52. doi: 10.1021/acs.jmedchem.6b00030. Epub 2016 Mar 23.

PMID:
26962886
45.

2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension.

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M.

Rev Esp Cardiol (Engl Ed). 2016 Feb;69(2):177. doi: 10.1016/j.rec.2016.01.002. No abstract available.

PMID:
26837729
46.

[2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension].

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M.

Kardiol Pol. 2015;73(12):1127-206. doi: 10.5603/KP.2015.0242. Polish. No abstract available.

47.

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M; ESC Scientific Document Group .

Eur Heart J. 2016 Jan 1;37(1):67-119. doi: 10.1093/eurheartj/ehv317. Epub 2015 Aug 29. No abstract available.

48.

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M.

Eur Respir J. 2015 Oct;46(4):903-75. doi: 10.1183/13993003.01032-2015. Epub 2015 Aug 29. Erratum in: Eur Respir J. 2015 Dec;46(6):1855-6.

49.

Prevalence and number of circulating tumour cells and microemboli at diagnosis of advanced NSCLC.

Mascalchi M, Falchini M, Maddau C, Salvianti F, Nistri M, Bertelli E, Sali L, Zuccherelli S, Vella A, Matucci M, Voltolini L, Pegna AL, Luconi M, Pinzani P, Pazzagli M.

J Cancer Res Clin Oncol. 2016 Jan;142(1):195-200. doi: 10.1007/s00432-015-2021-3. Epub 2015 Jul 26.

PMID:
26210156
50.

Pap smear in the prevention of HPV-related anal cancer: preliminary results of the study in a male population at risk.

Pisano L, Tiradritti L, Lorenzoni E, Zuccati G, Matucci M, Butera D, Foxi P, Confortini M.

G Ital Dermatol Venereol. 2016 Dec;151(6):619-627. Epub 2015 Jul 22.

PMID:
26199089

Supplemental Content

Support Center